US Regulators Reject Request to Clear Cheap Drug for Treatment of COVID-19

Contact Your Elected Officials
The Epoch Times Header

U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of COVID-19, drawing criticism from one of the doctors that asked for the clearance.

The Food and Drug Administration (FDA), in a 27-page memorandum explaining its decision, said that the benefit of fluvoxamine was โ€œnot persuasive when focusing on clinically meaningful outcomes such as proportion of patients experiencing hospitalizations or hospitalizations and deaths.โ€

A review of clinical trials that have examined fluvoxamine, a widely used antidepressant, against COVID-19 led to the conclusion that the data at this time are insufficient for emergency clearance, the FDA added.

Dr. David Boulware, who drew up the request because he believes more COVID-19 treatments are needed, said that the FDA erred because it used different criteria when analyzing fluvoxamine than when it analyzed drugs from major pharmaceutical companies, such as a pill from Pfizer called paxlovid.

Hospitalization was defined in the trials for those drugs as receiving over 24 hours of acute care, whether in a hospital or similar facility. But it analyzed hospitalization in the case of fluvoxamine only in hospitals, excluding similar facilities.

โ€œFDA should evaluate clinical trials using the same endpoint definitions for generic drugs as for big pharma. The deliberate creation of two-tiered system is inappropriate,โ€ Boulware, a professor of medicine at the University of Minnesota, said in a letter to Dr. Peter Stein, who is the director of the FDAโ€™s Office of New Drugs.

Asked for a comment on Boulwareโ€™s letter, an FDA spokesperson told The Epoch Times in an email that the agency after its review โ€œwas unable to reasonably conclude that fluvoxamine may be effective for the treatment of outpatient adults with COVID-19 to prevent severe disease progression and/or hospitalization.โ€

The COVID-19 Treatment Guidelines Panel, convened by the National Institutes of Health, says that it cannot recommend for or against fluvoxamine against COVID-19 due to โ€œinsufficient evidence.โ€

Supporters, though, note that some trials have shown efficacy against COVID-19.

Byย Zachary Stieber

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Why the Trump Administration is Sitting on the Epstein Files

President Trump, AG Bondi, and FBI Dir. Patel have the advantage over us in that they see the big overall picture when it comes to the Epstein List.

Trumpโ€™s โ€œMajor Statementโ€ On Russia Is A Clumsy Attempt To Thread The Needle

The โ€œmajor statementโ€ on Russia Trump hyped up turned out to be an attempt to thread the needle between escalating US involvement in Ukrainian and walking away from it.

AI Takes Customer Service from Doublespeak to Triplespeak

Corporations are replacing customer service agents with AI agents. Here's a real-life example of attempting to use AI to have my internet restored.

The Left’s Descent into Extremismย ย 

The political left, from mainstream Dems to radical Antifa, have embraced extremism, alienating swaths of the public and undermining their own influence.

Roger Stone Speaks About Trump at Turning Point USA

Longtime Donald Trump friend, Roger Stone, gave a speech at the 2025 TPUSA convention offering his take on the recent Epstein List controversy.

Border Czar Says Physical Appearance โ€˜Canโ€™t Be the Sole Reasonโ€™ to Detain Someone

Border czar Homan said comments were โ€œtaken out of contextโ€ and federal immigration enforcement agents can't detain people based on physical appearances alone.

Capacity of US Coal-Fired Power Plants to Fall Over 15 Percent by 2028

Total operating capacity of coal-fired power plants in US is set to drop to 145 GW by end of 2028, a 15% decline from the 172 GW in operation as of May.

Violence Against ICE Escalates Across America

ICE officers face increased confrontation on the street, which crosses the line between free speech and physical violence.

International Buyers Purchased $56 Billion Worth of US Homes in 1 Year

Foreign buyers purchased $56 billion worth of existing homes in the US between April 2024 and March 2025, up by 33.2% from the previous 12 months.

Trump to Announce $70 Billion Energy and Innovation Investment in Pittsburgh

President Trump is meeting with business leaders to discuss how best to meet the energy and computing needs of the future.

Attorney General Pam Bondi Dismisses Justice Departmentโ€™s Top Ethics Lawyer

AG Pam Bondi terminated the head of the DOJโ€™s ethics division, according to a letter posted to social media by the fired official.

Trumpโ€™s Potential Secondary Tariffs on Russia Would Clobber China, India

President Trump said he will impose โ€œvery severeโ€ secondary tariffs on Russia if President Putin does not agree to a cease-fire with Ukraine in 50 days. (09-14-22)

Trump Says He Spoke to Bongino Amid Reports of Infighting Over Epstein Files

President Trump spoke to FBI Deputy Dir. Dan Bongino, indicating the two remain close despite reported friction over release of Jeffrey Epstein docs.
spot_img

Related Articles